Poster: Rapid and Predictive Immunogenicity Risk Assessments Using In Silico Methods

by Elena Iemma | May 23, 2024

Poster: Comprehensive assessment of immunogenicity risk of host cell proteins in biologics and vaccines using in silico and in vitro methods

by Elena Iemma | May 23, 2024

Poster: An “I” (Immunogenicity Risk Assessment) for an Eye (Ophthalmology Biologics)

by Elena Iemma | May 23, 2024

Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis

by Elena Iemma | May 16, 2024

Development of IFNβ-1a versions with reduced immunogenicity and full in vitro biological activity for the treatment of multiple sclerosis

by Elena Iemma | Nov 15, 2023